Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tereza Jurková"'
Autor:
Fruzsina Kósa, Tereza Nečasová, Martin Špaček, Krzysztof Giannopoulos, Iwona Hus, Tereza Jurková, Eva Koriťáková, Marika Chrápavá, Martina Nováčková, Ivana Katinová, Denisa Krejčí, Adam Jujka, Zoltán Mátrai, István Vályi‐Nagy, Tadeusz Robak, Michael Doubek
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1961-1971 (2023)
Abstract This is the first large‐scale cross‐country analysis of patients with chronic lymphocytic leukemia (CLL) aimed to evaluate the incidence, types, and key prognostic factors of secondary malignancies, and to assess the impact on overall su
Externí odkaz:
https://doaj.org/article/6b13d5a7ca1c4d1cb8ebe689f64bb674
Autor:
Marek Baláž, Jiří Búřil, Tereza Jurková, Eva Koriťáková, Dušan Hrabovský, Jonáš Kunst, Petra Bártová, Jan Chrastina
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
BackgroundBilateral deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an effective treatment for refractory dystonia. Neuroradiological target and stimulation electrode trajectory planning with intraoperative microelectrode record
Externí odkaz:
https://doaj.org/article/fb1ce8cef2e440b8b4fd2361803a46b3
Autor:
Eva Korit́áková, Irena Doležalová, Jan Chládek, Tereza Jurková, Jan Chrastina, Filip Plešinger, Robert Roman, Martin Pail, Pavel Jurák, Daniel J. Shaw, Milan Brázdil
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
Background: Identifying patients with intractable epilepsy who would benefit from therapeutic chronic vagal nerve stimulation (VNS) preoperatively remains a major clinical challenge. We have developed a statistical model for predicting VNS efficacy u
Externí odkaz:
https://doaj.org/article/934ba43d5f7648ef9dd6b243707de457
Autor:
Fruzsina Kósa, Tereza Nečasová, Martin Špaček, Krzysztof Giannopoulos, Iwona Hus, Tereza Jurková, Eva Koriťáková, Marika Chrápavá, Martina Nováčková, Ivana Katinová, Denisa Krejčí, Adam Jujka, Zoltán Mátrai, István Vályi‐Nagy, Tadeusz Robak, Michael Doubek
Publikováno v:
Cancer medicineREFERENCES.
This is the first large-scale cross-country analysis of patients with chronic lymphocytic leukemia (CLL) aimed to evaluate the incidence, types, and key prognostic factors of secondary malignancies, and to assess the impact on overall survival based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60ff3313f5160554d9cf3fbf3edfd49
https://pubmed.ncbi.nlm.nih.gov/36205198
https://pubmed.ncbi.nlm.nih.gov/36205198
Autor:
Petra Belohlavkova, Daniela Zackova, Hana Klamova, Edgar Faber, Michal Karas, Lukas Stejskal, Eduard Cmunt, Olga Cerna, Ivana Jeziskova, Katerina Machova Polakova, Pavel Zak, Tereza Jurkova, Marika Chrapava, Jiri Mayer
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Background To evaluate the outcomes of first‐line imatinib versus nilotinib treatment for chronic myeloid leukemia in the chronic phase (CML‐CP) in real‐world clinical practice. Methods A propensity score analysis was performed to elim
Externí odkaz:
https://doaj.org/article/a3f1e095df1743329fc066dd5daac827